Recombinant Human HCRTR1 Protein，His

HCRTR1, or hypocretin receptor 1, is a G-protein-coupled receptor primarily involved in the regulation of arousal, wakefulness, and appetite, interacting with endogenous neuropeptides called hypocretins (or orexins). The discovery of hypocretins has provided significant insights into sleep disorders, particularly narcolepsy, a condition characterized by excessive daytime sleepiness and sudden sleep attacks. Genetic studies have shown that the loss of hypocretin-producing neurons in the hypothalamus contributes to narcolepsy, making HCRTR1 a promising target for therapeutic intervention. Researchers have focused on the structure-function relationship of HCRTR1 to better understand its role in neurotransmission and potential pathways for drug development. Recombinant HCRTR1 protein production allows for advanced studies on receptor binding, signaling mechanisms, and the pharmacology of potential agonists or antagonists. By utilizing techniques such as crystallography and ligand binding assays, scientists aim to elucidate the receptor's behavior in vitro, paving the way for novel treatments for sleep-related disorders and offering broader insights into the neurobiology of wakefulness and energy balance. This research is critical not only for addressing specific ailments like narcolepsy but also for understanding the complex interplay between sleep regulation and metabolic processes, highlighting the receptor's importance in both neurobiology and clinical applications.